 prevent alloimmun patient acut leukemia use white cell-reduc blood compon random trial platelet refractori hla alloimmun seriou complic transfus therapi prospect trial white cell wbc blood compon platelet red cell respect alloimmun refractori platelet increment transfus sixteen adult acut leukemia patient wbc-reduc platelet concentr pc red cell rbc unit fifteen control patient standard blood compon mean rbc wbc unit platelet loss cotton-wool filtrat percent rang fresh pc percent rang pc filtrat increment CI transfus fresh pc Cl hour filtrat store pc percent differ hour surviv wbc-reduc platelet number platelet unit group patient wbc-reduc group perman platelet refractori transient hla antibodi low titer patient control group patient refractori immun transient hla antibodi reduct wbc blood compon alloimmun